Surgery versus concurrent chemoradiotherapy for stage III non-small cell lung cancer: a retrospective study with propensity score matching

  • Published on //
  •  Reading time: 5 min.

Shigenobu Takao 1, Taniguchi Yuri 2, Suzuki Takahiro 1, Tabuchi Yuya 3, Sato Mizuki 3, Odagiri Kazumasa 3, Nakamura Yukiko 2, Shimokawa Tsuneo 2, Okamoto Hiroaki 2, Yoshizu Akira 1

1 https://ror.org/034s1fw96 Department of Thoracic Surgery Yokohama Municipal Citizen’s Hospital 1-1, Mitsuzawanishimachi, Kanagawa-ku 221-0855 Yokohama City Kanagawa Prefecture Japan
2 https://ror.org/034s1fw96 Department of Respiratory Medicine Yokohama Municipal Citizen’s Hospital Kanagawa Japan
3 https://ror.org/034s1fw96 Department of Radiation Oncology Yokohama Municipal Citizen’s Hospital Kanagawa Japan

Abstract

Background No study has directly compared the outcomes of surgery and concurrent chemoradiotherapy (cCRT) in patients with stage III non-small cell lung cancer (NSCLC) to date. This study aimed to compare the treatment efficacy of complete resection and definitive cCRT.
Methods Patients were recruited in this retrospective study from Yokohama Municipal Citizens’ Hospital between January 2013 and December 2022. We analyzed patients with pathological...

ContentGeneMD

To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in

Receive our newsletter to stay up to date with the latest news in

More articles

From peer-reviewed journals in